NAV

Castanospermine

Identification

Generic Name
Castanospermine
DrugBank Accession Number
DB01816
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 189.209
Monoisotopic: 189.100107973
Chemical Formula
C8H15NO4
Synonyms
  • (1S-(1α,6β,7α,8β,8αβ))-octahydro-1,6,7,8-indolizinetetrol
  • (1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine
  • 1,6,7,8-tetrahydroxyoctahydroindolizine
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UGlucan 1,3-beta-glucosidaseNot AvailableYeast
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Integrate drug-drug
interactions in your software
AbataceptThe risk or severity of adverse effects can be increased when Abatacept is combined with Castanospermine.
AdalimumabThe risk or severity of adverse effects can be increased when Adalimumab is combined with Castanospermine.
Adenovirus type 7 vaccine liveThe risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Castanospermine.
AldesleukinThe risk or severity of adverse effects can be increased when Aldesleukin is combined with Castanospermine.
AlefaceptThe risk or severity of adverse effects can be increased when Alefacept is combined with Castanospermine.
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Indolizidines
Sub Class
Not Available
Direct Parent
Indolizidines
Alternative Parents
Piperidines / N-alkylpyrrolidines / Trialkylamines / Secondary alcohols / 1,2-aminoalcohols / Polyols / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
1,2-aminoalcohol / Alcohol / Aliphatic heteropolycyclic compound / Amine / Azacycle / Hydrocarbon derivative / Indolizidine / N-alkylpyrrolidine / Organic nitrogen compound / Organic oxygen compound
Molecular Framework
Aliphatic heteropolycyclic compounds
External Descriptors
indolizidine alkaloid (CHEBI:27860) / Indolizidine alkaloids (C02256)
Affected organisms
Not Available

Chemical Identifiers

UNII
Q0I3184XM7
CAS number
79831-76-8
InChI Key
JDVVGAQPNNXQDW-TVNFTVLESA-N
InChI
InChI=1S/C8H15NO4/c10-4-1-2-9-3-5(11)7(12)8(13)6(4)9/h4-8,10-13H,1-3H2/t4-,5-,6+,7+,8+/m0/s1
IUPAC Name
(1S,6S,7R,8R,8aR)-octahydroindolizine-1,6,7,8-tetrol
SMILES
[H][C@]1(O)CCN2C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]12[H]

References

General References
Not Available
KEGG Compound
C02256
PubChem Compound
54445
PubChem Substance
46507978
ChemSpider
49177
BindingDB
36388
ChEBI
27860
ChEMBL
CHEMBL311226
ZINC
ZINC000003775177
PDBe Ligand
CTS
Wikipedia
Castanospermine
PDB Entries
1eqc / 2cbu / 2jkp / 2pwg / 2vl8 / 4iif / 5ied

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1110.0 mg/mLALOGPS
logP-2.1ALOGPS
logP-2.6Chemaxon
logS0.77ALOGPS
pKa (Strongest Acidic)12.89Chemaxon
pKa (Strongest Basic)8.96Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area84.16 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity44.44 m3·mol-1Chemaxon
Polarizability18.78 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.8918
Blood Brain Barrier-0.603
Caco-2 permeable-0.5805
P-glycoprotein substrateSubstrate0.6783
P-glycoprotein inhibitor INon-inhibitor0.8961
P-glycoprotein inhibitor IINon-inhibitor0.9806
Renal organic cation transporterNon-inhibitor0.6639
CYP450 2C9 substrateNon-substrate0.8783
CYP450 2D6 substrateNon-substrate0.6942
CYP450 3A4 substrateSubstrate0.5188
CYP450 1A2 substrateNon-inhibitor0.8141
CYP450 2C9 inhibitorNon-inhibitor0.9406
CYP450 2D6 inhibitorNon-inhibitor0.9231
CYP450 2C19 inhibitorNon-inhibitor0.939
CYP450 3A4 inhibitorNon-inhibitor0.9974
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9942
Ames testNon AMES toxic0.7775
CarcinogenicityNon-carcinogens0.9757
BiodegradationNot ready biodegradable0.9638
Rat acute toxicity2.3961 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.6611
hERG inhibition (predictor II)Non-inhibitor0.9173
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (4 TMS)GC-MSsplash10-00o0-1932000000-28a09bc636766bb094b0
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-05i1-3900000000-79c362462b4860796274
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0006-3900000000-75396d0a5940c9e29a57
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-006x-2900000000-079bdf1716f2d906311b
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-02ms-9800000000-e528e43709795f6c7798
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-030r-9200000000-8d9a667a9121223e0f3e
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-00lr-9000000000-1798e7ef1f3d1099d86d
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-0900000000-8cea82fa37893c5c5b3a
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-052r-3900000000-d04e6d7f2e585d2f5af1
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0fdo-0900000000-93004dc2fac245e67a03
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-055e-9700000000-a5ec5e35a293ea4aa17e
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-07w9-9800000000-3b4f3da5ac877712a01f
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-9300000000-467948666cc122232391
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-141.8626672
predicted
DarkChem Lite v0.1.0
[M-H]-143.55196
predicted
DeepCCS 1.0 (2019)
[M+H]+142.3632672
predicted
DarkChem Lite v0.1.0
[M+H]+145.94751
predicted
DeepCCS 1.0 (2019)
[M+Na]+141.9114672
predicted
DarkChem Lite v0.1.0
[M+Na]+152.29817
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Glucan 1,3-beta-glucosidase
Kind
Protein
Organism
Yeast
Pharmacological action
Unknown
General Function
Transferase activity
Specific Function
Major glucan 1,3-beta-glucosidase required for cell wall integrity. Beta-glucanases participate in the metabolism of beta-glucan, the main structural component of the cell wall. Can also function b...
Gene Name
XOG1
Uniprot ID
P29717
Uniprot Name
Glucan 1,3-beta-glucosidase
Molecular Weight
50037.635 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52